Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy
- PMID: 17547887
- PMCID: PMC1949426
- DOI: 10.1016/j.ajog.2007.01.005
Live birth patterns among human immunodeficiency virus-infected women before and after the availability of highly active antiretroviral therapy
Abstract
Objective: The objective of the study was to investigate the relationship between human immunodeficiency virus (HIV) infection and childbearing before and after the availability of highly active antiretroviral therapy (HAART).
Methods: Enrollment in the Women's Interagency HIV study took place in 1994-1995 (pre-HAART era) and again in 2001-2002 (HAART era). Live birth rates prior to enrollment were compared between treatment era cohorts for HIV-infected and HIV-uninfected women aged 15-44 years using Poisson regression. For HIV-infected women, we included live births between HIV diagnosis date and study entry; the HAART era cohort included only women diagnosed with HIV in 1996 and afterward.
Results: Among HIV-infected women, the HAART era live birth rate was 150% higher than in the pre-HAART era (P = .001) vs a 5% increase among HIV-uninfected women. The rate of increase in live birth rate was higher for women > or = 35 years old (vs younger than 25 years, P = .02), and with more than a high school education (vs. less than high school, P = .05).
Conclusion: The availability of effective therapeutic interventions has had a profound impact on child-bearing among HIV-infected women.
References
-
- UNAIDS/WHO AIDS Epidemic. Update December 2002 http://www.unaids.org/en/other/functionalities/ViewDocument.asp?href=htt....
-
- Trends in HIV/AIDS Diagnoses-33 States, 2001–2004 MMWR weekly. 2005 Nov 18;54(45):1149–53. - PubMed
-
- Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–60. - PubMed
-
- Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Women and Infants’ Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484–94. - PubMed
-
- Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002 Jul 10;288(2):189–98. - PubMed
Publication types
MeSH terms
Grants and funding
- M01 RR000079/RR/NCRR NIH HHS/United States
- U01 DK066116/DK/NIDDK NIH HHS/United States
- U01-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- U01-AI-34994/AI/NIAID NIH HHS/United States
- U01-AI-35004/AI/NIAID NIH HHS/United States
- U01-AI-31834/AI/NIAID NIH HHS/United States
- M01-RR-00079/RR/NCRR NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- U01-AI-34993/AI/NIAID NIH HHS/United States
- M01 RR000083/RR/NCRR NIH HHS/United States
- U01-HD-32632/HD/NICHD NIH HHS/United States
- U01 CA066535/CA/NCI NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- M01-RR-00083/RR/NCRR NIH HHS/United States
- M01-RR-00071/RR/NCRR NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- U01-AI-34989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
